Carcinoma of the penis is rare in this country. A total of 219 patients diagnosed to have carcinoma of the penis were analyzed retrospectively. The primary penile lesion was treated by partial amputation in 160 patients. Forty‐two patients had inguinal node dissection. Forty‐six patients received radiation therapy to the inguinal region. Sixty‐five per cent of the patients with no palpable nodes at initial diagnosis survived for six or more years. Twenty‐eight per cent of the patients with palpable nodes survived for three to five years, and 15% for six or more years. Ten per cent of the patients died of a second primary tumor.

Records of 1,068 patients with malignant lymphomas were reviewed from a more than 10-year interval for any evidence of lymphomatous involvement of the urogenital tract. Of the 1,068 patients 72 (6.7 per cent) had urologic findings related to lymphoma either at autopsy, radiographically or at operation. Of 400 cases 23 (5.8 per cent) with Hodgkin's and 49 of 668 cases (7.3 per cent) with non-Hodgkin's lymphoma had some evidence of urogenital involvement at some point in the course of the disease. In the total group reviewed the rate of involvement was low (6.7 per cent) and was essentially equal for patients with Hodgkin's and non-Hodgkin's lymphomas. We herein illustrate various forms of urogenital tract problems encountered in patients with solid lymphatic tumors.

A retrospective analysis of 30 patients with primary sarcoma of the bladder and prostate is presented. Prognosis seems to be better in adults irrespective of the type of treatment. The survival rate is poor for children with sarcoma of the prostate. Two children were cured of sarcoma of the bladder by a radical operation. Sarcomas of the bladder and prostate are more common in adults more than 50 years old. The type of treatment and the results are reviewed. The place of multimodal treatment in the management of these sarcomas is discussed.

No abstract